The biology and life-cycle of human papillomaviruses J Doorbar, W Quint, L Banks, IG Bravo, M Stoler, TR Broker, MA Stanley Vaccine 30, F55-F70, 2012 | 1785 | 2012 |
Molecular biology of human papillomavirus infection and cervical cancer J Doorbar Clinical science 110 (5), 525-541, 2006 | 1677 | 2006 |
The papillomavirus life cycle J Doorbar Journal of clinical virology 32, 7-15, 2005 | 1335 | 2005 |
Human papillomavirus molecular biology and disease association J Doorbar, N Egawa, H Griffin, C Kranjec, I Murakami Reviews in medical virology 25, 2-23, 2015 | 1082 | 2015 |
Carcinogenic human papillomavirus infection M Schiffman, J Doorbar, N Wentzensen, S De Sanjosé, C Fakhry, ... Nature reviews Disease primers 2 (1), 1-20, 2016 | 907 | 2016 |
Comprehensive control of human papillomavirus infections and related diseases FX Bosch, TR Broker, D Forman, AB Moscicki, ML Gillison, J Doorbar, ... Vaccine 31, H1-H31, 2013 | 783 | 2013 |
Human papillomaviruses; epithelial tropisms, and the development of neoplasia N Egawa, K Egawa, H Griffin, J Doorbar Viruses 7 (7), 3863-3890, 2015 | 630 | 2015 |
Specific interaction between HPV-16 E1–E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network J Doorbar, S Ely, J Sterling, C McLean, L Crawford Nature 352 (6338), 824-827, 1991 | 578 | 1991 |
Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers K Middleton, W Peh, S Southern, H Griffin, K Sotlar, T Nakahara, ... Journal of virology 77 (19), 10186-10201, 2003 | 417 | 2003 |
The E4 protein; structure, function and patterns of expression J Doorbar Virology 445 (1-2), 80-98, 2013 | 345 | 2013 |
The low-risk papillomaviruses N Egawa, J Doorbar Virus research 231, 119-127, 2017 | 307 | 2017 |
Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line J Doorbar, A Parton, K Hartley, L Banks, T Crook, M Stanley, L Crawford Virology 178 (1), 254-262, 1990 | 272 | 1990 |
Life cycle heterogeneity in animal models of human papillomavirus-associated disease WL Peh, K Middleton, N Christensen, P Nicholls, K Egawa, K Sotlar, ... Journal of virology 76 (20), 10401-10416, 2002 | 253 | 2002 |
Identification of the human papilloma virus‐1a E4 gene products. J Doorbar, D Campbell, RJ Grand, PH Gallimore The EMBO journal 5 (2), 355-362, 1986 | 252 | 1986 |
Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression GA Maglennon, P McIntosh, J Doorbar Virology 414 (2), 153-163, 2011 | 243 | 2011 |
Characterization of events during the late stages of HPV16 infectionin vivousing high-affinity synthetic fabs to E4 J Doorbar, C Foo, N Coleman, L Medcalf, O Hartley, T Prospero, ... Virology 238 (1), 40-52, 1997 | 226 | 1997 |
One virus, one lesion—individual components of CIN lesions contain a specific HPV type W Quint, D Jenkins, A Molijn, L Struijk, M van de Sandt, J Doorbar, J Mols, ... The Journal of pathology 227 (1), 62-71, 2012 | 218 | 2012 |
Papillomavirus life cycle organization and biomarker selection J Doorbar Disease markers 23 (4), 297-313, 2007 | 218 | 2007 |
Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin K Matthews, CM Leong, L Baxter, E Inglis, K Yun, BT Bäckström, ... Journal of virology 77 (15), 8378-8385, 2003 | 213 | 2003 |
Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a J Doorbar, PH Gallimore Journal of virology 61 (9), 2793-2799, 1987 | 205 | 1987 |